The House of Representatives Energy and Commerce Committee and the Senate Health, Education, Labor and Pensions Committee will both be holding hearings regarding the NECC meningitis case. The House hearing is first, followed by the Senate. The investigation will hedge around past issues and violation by NECC and they have also been invited to speak if they wish.
Ameridose Sister Company of NECC Company Linked to Meningitis Outbreak – FDA Recall for “All” Their Drugs Which May Worsen Existing Shortage of Sterile Injectable Drugs
Perhaps this could make a point of the FDA needing funds to be able to investigate and and take action as needed as they don’t have the staff at present and there is talk to cut funds to both the FDA and NIH. This could also stand to open full discussion about giving the agency more control over compounding companies. BD
One More Good Reason to Tax the Data Sellers– Create Additional Funding for the NIH and FDA From Sources That Otherwise Are Too Greedy to Share & Contribute
Food and Drug Administration (FDA) Commissioner Margaret Hamburg is scheduled to testify before lawmakers on the outbreak of fungal meningitis that has killed 30 nationwide.
The outbreak has been linked to tainted steroid injections distributed by the New England Compounding Center (NECC), a Framingham, Mass.-based drug compounder that has now surrendered its license and recalled its products.
Federal health officials first learned of the outbreak in late September, and Congress has been pushing for details while in recess.